Pfizer Names Jeffrey Kindler To Succeed Hank McKinnell As CEO - Update

Posted by john on July 31st, 2006 — in Celebrex Top News

The other two executives who were contending for the post of CEO were Karen Katen, president of the company’s human health division, and David Shedlarz, the chief financial officer.
Kindler succeeds Hank McKinnell, who will remain Pfizer’s chairman of the board until his retirement in February 2007. McKinnell’s retirement was originally slated for February 2008.
Kindler, who […]

Increased Danger of Using Pain Medications Enhances Demand for New Drug-Free Pain Treatment

Posted by john on July 24th, 2006 — in Celebrex Top News

As pain medication becomes more dangerous, people in chronic pain are using Emotional Freedom Techniques (EFT) to gain relief. EFT is a do-it-yourself acupressure technique that targets the roots of pain; it does not mask pain. More than a decade of EFT case studies indicate that chronic pain is a result of unresolved emotional issues […]

Lipitor sales boost Pfizer profits

Posted by john on July 23rd, 2006 — in Celebrex Top News

Pfizer Inc. said Thursday that second-quarter profit, excluding certain one-time charges and tax benefits, increased 10 percent on higher revenues from sales of its blockbuster cholesterol fighter Lipitor.
Still, sales of Lipitor, the biggest selling drug in the world, rose 9 percent during the quarter to $3.1 billion based primarily on higher prices charged to consumers, […]

Ibuprofen May Not Be Ideal Remedy For Sprains

Posted by john on July 19th, 2006 — in Celebrex Top News

Ibuprofen is often used to relieve swelling and pain from a sprain but a new study found it may do more harm than good.
The study in the Journal of Sports Medicine found Ibuprofen may counteract the body’s natural healing process. Normally swelling and inflammation helps a ligament heal and heal strongly.
Taking pills to relieve inflammation […]

Ultrasound good, drugs bad for knee injury

Posted by john on July 15th, 2006 — in Celebrex Top News

Treatment with low-intensity pulsed ultrasound can hasten the healing of torn ligaments in the knee, while the use of NSAID drugs, such as Celebrex (celecoxib) and Motrin (ibuprofen), has the opposite effect, findings from an animal study suggest.
Ligaments are strong fibrous bands that connect bones and help control their range of motion. They are closely […]

Tillery searches phone books to prove Pfizer connection

Posted by john on July 11th, 2006 — in Celebrex Top News

St. Louis attorney Stephen Tillery claimed he could prove that drug maker Pfizer did business in Madison County, but his search for proof in phone books has turned up nothing but a wrong number.
Tillery found Pfizer in a Planet Pages directory for Madison and St. Clair counties, but according to Pfizer the number belonged to […]

Health Canada rejects call to restrict ibuprofen access

Posted by john on July 7th, 2006 — in Celebrex Top News

Health Canada is rejecting the advice of its own expert panel to move ibuprofen behind the counter despite new British findings that high doses carry the same risk of heart attack as Vioxx.
An advisory panel recommended last year that ibuprofen be sold only after a discussion with a pharmacist about possible cardiovascular risks. Over-the-counter versions […]

Acetaminophen Use Could Trigger Liver Damage

Posted by john on July 5th, 2006 — in Celebrex Top News

In a new study, people who repeatedly took the maximum recommended daily dose of acetaminophen developed abnormalities in blood tests that can be a signal for liver damage.
The study researchers said they first noted the potential for liver toxicity in patients treated for pain with a combination of the opioid hydrocodone plus acetaminophen. But, before […]

Seniors See Rising Drug Prices Despite Benefit

Posted by john on July 3rd, 2006 — in Celebrex Top News

When the prescription drug program was being created, one of the most controversial elements banned Medicare from using its massive purchasing power to negotiate lower drug prices — instead letting individual plans negotiate on their own. Now, critics say, there’s evidence that that decision is costing senior citizens and taxpayers.
Like millions of seniors, Joan Katz […]